Mortgage Rates Mixed as of May 24 2026 30Year Fixed Dips 15Year Rises Forbes Seeks Nominations for Inaugural List of Americas Top AI Consultants in CPA Firms AI DataCenter Boom Strains US Power Grid May Push Utility Bills Higher Diversified Energy Acquires Maverick Natural Resources in Permian Basin Deal Super Micro Computer Sales More Than Double but Some Analysts Advise Caution UK Exports to US Plunge 25 as Trump Tariffs Create Trade Deficit With Largest Partner Transcontinental Realty Investors Inc TCI Q1 2025 Earnings Positive Earnings Amid Quiet Reporting ZUMZ Q1 2026 Earnings EPS Beats Estimates by 55 Shares Rise ORIO Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Discipline LIXT Q4 2024 Earnings PreRevenue Biotech Reports PerShare Loss as Stock Jumps 136 Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet MLP Q1 2024 Earnings Net Loss Persists Stock Declines Tevogen Bio Holdings TVGN Slides 105 as Selling Pressure Intensifies Golden Heaven Group Holdings GDHG Slides 284 as Shares Test Key Support Near 162 American Eagle Outfitters AEO Bounces 36 as Retail Sector Finds Footing Tempest Therapeutics TPST Edges Higher as Biotech Sector Shows Renewed Interest RGC Resources RGCO Edges Higher as Stock Approaches Key Resistance Level UK Bank Holiday Travel Delays and Record Heat Signal Busy Summer for Travel Sector NESR Q1 2026 Earnings EPS Surprise of 1987 Beats Estimates Stock Slides 2 Smith Nephew SNN Sheds 113 as Stock Tests Key Support Levels OraSure Technologies Inc OSUR Q1 2026 Earnings WiderthanExpected Loss Raises Concerns Despite Stock Surge Peoples Financial Services Corp Q1 2026 Earnings EPS Misses Estimates by 795 Stock Declines Nakamoto Inc NAKA Q4 2025 Earnings EPS Misses Estimates Stock Rises Amid Uncertainty BNS Q1 2026 Earnings EPS Beats Estimates as Bank Delivers Strong Core Performance Atlanticus Holdings ATLCP Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat Stock Rises OCS Q1 2026 Earnings WiderthanExpected Losses Amid Continued Pipeline Investment ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues